Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rieckmann

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Journal of Neural Transmission. Supplementum|January 1, 1997
Pathogenesis of immune-mediated demyelination in the CNSH P Hartung, P Rieckmann
International Journal of Clinical Practice|September 6, 2007
Emerging oral therapies for multiple sclerosisB A Cohen, P Rieckmann
European Neurology|October 26, 1999
Escalating immunotherapy of multiple sclerosis.Austrian-German- Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG]P Rieckmann, K V Toyka
Neurology|July 26, 2000
Effect of interferon beta on human myelin basic protein-specific T-cell lines: comparison of IFNbeta-1a and IFNbeta-1bG Francis, F Weber, P Rieckmann
Deutsche Medizinische Wochenschrift (1946)|November 24, 1998
[Juvenile cerebral ischaemia caused by designer drugs]R Giess, P Rieckmann, W Müllges
Deutsche Medizinische Wochenschrift (1946)|August 14, 2001
[Ciguatera: clinical relevance of a marine neurotoxin]K Ruprecht, P Rieckmann, R Giess
Der Internist|March 23, 1999
[Successful treatment of multiple sclerosis with beta-interferon]P Rieckmann, R Gold, K Toyka
Klinische Wochenschrift|January 4, 1990
Class differentiation of immunoglobulin-containing cerebrospinal fluid cells in inflammatory diseases of the central nervous systemP Rieckmann, T Weber, K Felgenhauer
Multiple Sclerosis and Related Disorders|December 19, 2020
Introduction of the Watzmann Severity Scale: A sensorimotor approach to estimate the course of inpatient rehabilitation in multiple sclerosisP Gulde, J Hermsdörfer, P Rieckmann
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2004
Local pain during REBIF injection is not due to acidic pHM Buttmann, M Goebeler, P Rieckmann
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Journal of Neural Transmission. Supplementum|January 1, 1997
Pathogenesis of immune-mediated demyelination in the CNSH P Hartung, P Rieckmann
International Journal of Clinical Practice|September 6, 2007
Emerging oral therapies for multiple sclerosisB A Cohen, P Rieckmann
European Neurology|October 26, 1999
Escalating immunotherapy of multiple sclerosis.Austrian-German- Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG]P Rieckmann, K V Toyka
Neurology|July 26, 2000
Effect of interferon beta on human myelin basic protein-specific T-cell lines: comparison of IFNbeta-1a and IFNbeta-1bG Francis, F Weber, P Rieckmann
Deutsche Medizinische Wochenschrift (1946)|November 24, 1998
[Juvenile cerebral ischaemia caused by designer drugs]R Giess, P Rieckmann, W Müllges
Deutsche Medizinische Wochenschrift (1946)|August 14, 2001
[Ciguatera: clinical relevance of a marine neurotoxin]K Ruprecht, P Rieckmann, R Giess
Der Internist|March 23, 1999
[Successful treatment of multiple sclerosis with beta-interferon]P Rieckmann, R Gold, K Toyka
Klinische Wochenschrift|January 4, 1990
Class differentiation of immunoglobulin-containing cerebrospinal fluid cells in inflammatory diseases of the central nervous systemP Rieckmann, T Weber, K Felgenhauer
Multiple Sclerosis and Related Disorders|December 19, 2020
Introduction of the Watzmann Severity Scale: A sensorimotor approach to estimate the course of inpatient rehabilitation in multiple sclerosisP Gulde, J Hermsdörfer, P Rieckmann
Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2004
Local pain during REBIF injection is not due to acidic pHM Buttmann, M Goebeler, P Rieckmann
Pageof 15